×
About 19,955 results

Unique Nationwide Screening Program Fails to Move the Needle on CVD Risk Factors
https://www.medpagetoday.com/primarycare/preventivecare/102002

Dec 1st, 2022 - Japan's mass screening and counseling intervention resulted in only modest population-wide improvements in obesity and cardiovascular disease (CVD) risk factors, a study showed. Among over 3.4 million men and 2.3 million women, those who met the threshold for high waist circumference with high blood pressure, impaired glucose tolerance, or dyslipidemia and received lifestyle guidance and counse...

No Help From Vitamin D Supplements; COVID-19 Severity Linked to Genes; and Salting Food Less Lowers Cardiac Risk
https://www.medscape.com/viewarticle/984694

Nov 30th, 2022 - No Help From Vitamin D Supplements A new study adds to evidence that vitamin D supplements don't do much for health, said Medscape writer F. Perry Wilson, MD, MSCE, of the Yale School of Medicine. Children in Ulaanbaatar, Mongolia, showed no difference in the rate of latent tuberculosis infection after 3 years of vitamin D3 supplements compared with children who got only a placebo, according to...

Ultra-Long Stroke Transfers; Isotopes Return; Back-to-Back CPR During Half Marathon
https://www.medpagetoday.com/cardiology/prevention/101958

Nov 29th, 2022 - Persistent asthma was linked to higher carotid plaque burden and inflammation in the MESA cohort. (Journal of the American Heart Association) Hospitals can still make endovascular therapy work for stroke patients transferred from over 300 miles away, suggested a retrospective study from New Zealand and Australia. (Stroke) Good news during the medical radioisotope shortage: the global supply of ...

Lupus Linked With Greater Risk of Cardiovascular Complications of Childbirth
https://www.medpagetoday.com/rheumatology/lupus/101954

Nov 29th, 2022 - Pregnant women with systemic lupus erythematosus (SLE) were more prone to cardiovascular complications during delivery, and their risk seems to have increased over the past 15 years, according to national administrative data. The cross-sectional study supports the role that the underlying inflammatory activity of SLE may play in these cardiovascular complications, since even after adjustment fo...

New Studies Change Beliefs About Cardiovascular Disease
https://www.medscape.com/viewarticle/984181

Nov 29th, 2022 - This transcript has been edited for clarity. Recently, there have been a series of published studies in the realm of cardiovascular disease that have changed certain beliefs we've held in the past. I'm going to review a few of these. The first is the TIME study. The TIME study looked at whether it matters if you give antihypertensive agents in the morning or the evening. This was a prospective,...

AFib Risk Rises as A1c Increases
https://www.medscape.com/viewarticle/984714

Nov 29th, 2022 - Researchers published the study covered in this summary on Research Square as a preprint that has not yet been peer reviewed. Key Takeaways Adults not receiving glucose-lowering drugs showed a stepwise, increasing risk of developing atrial fibrillation (AFib) that tracked with increasing levels of A1c from 5.8% to 7.6% (40 to 60 mmol/mol). Patients with new-onset diabetes had a similar risk of ...

Adding Salt to Food Linked to Higher CVD Risk
https://www.medscape.com/viewarticle/984718

Nov 29th, 2022 - A lower frequency of adding salt to food is associated with lower risk of cardiovascular disease, particularly heart failure and ischemic heart disease, a new study has found. The study analyzed the association of adding salt to food and incident cardiovascular disease risk in 176,570 adults participating in the UK Biobank database. Results showed that a lower frequency of adding salt to foods ...

Elevated Lp(a) Tied to More Early CV Events Than FH
https://www.medscape.com/viewarticle/984693

Nov 28th, 2022 - Many more people are at risk for early cardiovascular events because of raised Lp(a) levels than from having familial hypercholesterolemia (FH), a new study suggests. The Danish study set out to try and establish a level of Lp(a) that would be associated with a cardiovascular risk similar to that seen with FH. As there are many different definitions of FH, results showed a large range of Lp(a) ...

ECG Challenge: Irregular Pulse During Cardiology Visit
https://www.medscape.com/viewarticle/984169

Nov 28th, 2022 - A 58-year-old man with a history of hypertension (treated with amlodipine and hydrochlorothiazide) and coronary artery disease (treated with a beta-blocker and isosorbide mononitrate) visits his cardiologist for a routine physical examination. His pulse is noted to be irregular, and a 12-lead ECG is obtained. Figure 1.

Does Lipoprotein(a) Play a Causal Role in Atherosclerotic Cardiovascular Disease?
https://www.medscape.com/viewarticle/983641

Nov 28th, 2022 - This transcript has been edited for clarity. Michelle L. O'Donoghue, MD, MPH: Hi. I'm Dr Michelle O'Donoghue. I'm a cardiologist at Brigham and Women's Hospital, and I'm reporting for Medscape. Joining me today is Dr Stephen Nicholls. He's a professor of cardiology at Monash University in Australia. Welcome. Stephen J. Nicholls, MBBS, PhD: Thanks. O'Donoghue: He's really a world expert on the f...

Combo Treatment Could Delay Kidney Failure for Years in Nondiabetic CKD
https://www.medpagetoday.com/nephrology/esrd/101909

Nov 23rd, 2022 - Combining the powers of SGLT2 and renin-angiotensin-aldosterone system (RAAS) inhibitor therapy could substantially reduce the risk of kidney failure or death for patients with albuminuric, nondiabetic chronic kidney disease (CKD), researchers predicted. In an analysis calculated using trial-level estimates, adding an angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker...

Illegal Diet Supplements for CVD; Lung Disease in OAC Users; Myocarditis Mechanism
https://www.medpagetoday.com/cardiology/prevention/101876

Nov 22nd, 2022 - FDA sent warnings to seven companies selling dietary supplements with unlawful claims of treating or preventing cardiovascular disease. A study from Taiwan showed that there was an increased risk of interstitial lung disease in people using oral anticoagulants (OACs), specifically factor Xa inhibitors, including rivaroxaban (Xarelto), apixaban (Eliquis), and edoxaban (Savaysa), for atrial fibri...

New Risk Score Predicts Dementia Probability
https://www.medscape.com/viewarticle/984486

Nov 22nd, 2022 - Researchers have developed a point-based score that can help clinicians predict an individual's risk of developing dementia over 13 years, allowing for early action to delay or prevent cognitive problems. However, some experts are skeptical. The risk score does not require neuroimaging and "may achieve nearly 100% prediction accuracy," study investigator Xi-jian Dai, PhD, with The Second Affili...

A Medically Tailored Holiday Meal
https://www.medscape.com/viewarticle/984357

Nov 21st, 2022 - The holidays are here, and it is time for those delicious dishes we think about all year. But what about friends, family, and patients who may have certain health conditions and must watch what they eat? Medscape asked for recipes from several organizations across the United States that specialize in health-conscious meals with a dash of culinary creativity. Their tasty dishes are served to peo...

Telehealth Works for CVD Care, But Challenges Ahead: AHA
https://www.medscape.com/viewarticle/984412

Nov 21st, 2022 - Telehealth has become a proven and valuable way to deliver cardiovascular disease (CVD) care, but ongoing limitations, including access to technology, hinder widespread adoption, the American Heart Association (AHA) concludes in a new scientific statement. "Telehealth utilization grew tremendously during the COVID-19 pandemic. This timely AHA scientific statement highlights strengths and limita...

Opioids Increase Risk for All-Cause Deaths in RA vs. NSAIDs
https://www.medscape.com/viewarticle/984286

Nov 17th, 2022 - PHILADELPHIA — For patients with rheumatoid arthritis who are already at increased risk for major adverse cardiovascular events (MACE), NSAIDs may be safer than opioids, results of a new-user active comparator study suggest. Dr Gulsen Ozen Among 6,866 patients with RA who started on opioids and 13,698 patients who started on NSAIDs for pain, the use of both weak and strong opioids was associate...

Prednisone, Colchicine Equally Efficacious for CPP Arthritis
https://www.medscape.com/viewarticle/984111

Nov 16th, 2022 - PHILADELPHIA — Prednisone appears to have the edge over colchicine for control of pain in patients with acute calcium pyrophosphate (CPP) crystal arthritis, an intensely painful rheumatic disease primarily affecting older patients. Among 111 patients with acute CPP crystal arthritis randomized to receive either prednisone or colchicine for control of acute pain in a multicenter study, 2 days of...

Sham-Controlled Renal Denervation Trial for Hypertension Is a Near Miss
https://www.medscape.com/viewarticle/984167

Nov 16th, 2022 - CHICAGO – Renal denervation, relative to a sham procedure, was linked with statistically significant reductions in blood pressure in the newly completed SPYRAL HTN–ON MED trial, but several factors are likely to have worked in concert to prevent the study from meeting its primary endpoint. Of these differences, probably none was more important than the substantially higher proportion of patient...

Morning vs Midday Exercise; LVADs and Cancer; Reperfusion Injury After Thrombectomy
https://www.medpagetoday.com/cardiology/prevention/101759

Nov 15th, 2022 - Is diabetes slipping in importance as a cardiovascular risk factor? (JAMA) Morning exercisers in the U.K. Biobank tended to have lower cardiovascular disease risk than those saving their physical activity for midday. (European Journal of Preventive Cardiology) Models incorporating risk factors and coronary artery calcium scores trumped the traditional prediction model for myocardial infarction ...

Tirzepatide Cuts BP During Obesity Treatment
https://www.medscape.com/viewarticle/984068

Nov 15th, 2022 - CHICAGO — Treatment with the "twincretin" tirzepatide led to significant and potentially clinically meaningful cuts in 24-hour ambulatory blood pressure, compared with placebo, while causing modest increases in heart rate, in a prespecified substudy of the SURMOUNT-1 trial. "The large effects on ambulatory 24-hour blood pressure raise the possibility that there may be important long-term benefi...